|
平成23年の東京都保菌者検索事業実施結果が確定いたしましたので、下記の通りお知らせします。
食品監視課食中毒調査係
1 腸管出血性大腸菌の発生状況累計グラフ
（1）散発患者発生動向調査
| |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
| O157VT1 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
| O157VT2 |
1 |
0 |
0 |
0 |
0 |
3 |
0 |
1 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
2 |
4 |
| O157VT1,2 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
2 |
1 |
0 |
3 |
4 |
1 |
0 |
1 |
1 |
3 |
| その他 |
0 |
0 |
0 |
1 |
0 |
0 |
0 |
1 |
2 |
1 |
0 |
1 |
0 |
1 |
0 |
0 |
3 |
3 |
| 累計 |
1 |
1 |
1 |
2 |
2 |
6 |
6 |
8 |
12 |
14 |
14 |
18 |
22 |
24 |
24 |
25 |
31 |
41 |
| |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
| O157VT1 |
0 |
1 |
1 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
| O157VT2 |
1 |
5 |
2 |
0 |
2 |
0 |
3 |
0 |
3 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
| O157VT1,2 |
5 |
9 |
22 |
11 |
4 |
6 |
2 |
1 |
2 |
2 |
1 |
3 |
4 |
2 |
2 |
1 |
0 |
0 |
| その他 |
2 |
4 |
3 |
0 |
1 |
2 |
4 |
0 |
1 |
1 |
0 |
0 |
0 |
1 |
0 |
0 |
0 |
0 |
| 累計 |
49 |
68 |
96 |
107 |
114 |
122 |
131 |
132 |
138 |
141 |
142 |
145 |
149 |
152 |
154 |
155 |
155 |
155 |
（２）無症状病原体保有者調査
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| O157VT1 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
| O157VT2 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
2 |
0 |
0 |
0 |
0 |
2 |
2 |
2 |
| O157VT1,2 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
1 |
| その他 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
| 累計 |
0 |
0 |
0 |
0 |
0 |
0 |
2 |
3 |
3 |
3 |
5 |
5 |
5 |
5 |
5 |
8 |
10 |
13 |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| O157VT1 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
| O157VT2 |
0 |
1 |
1 |
0 |
2 |
1 |
1 |
1 |
2 |
1 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
| O157VT1,2 |
0 |
1 |
2 |
1 |
0 |
0 |
0 |
1 |
0 |
1 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
| その他 |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
1 |
1 |
1 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
| 累計 |
13 |
15 |
18 |
19 |
22 |
23 |
24 |
27 |
30 |
33 |
34 |
34 |
34 |
34 |
34 |
34 |
35 |
35 |
2 サルモネラの発生状況累計グラフ
（1）散発患者発生動向調査
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| O4 |
0 |
0 |
1 |
0 |
0 |
1 |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
| O7 |
0 |
1 |
0 |
0 |
0 |
1 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
1 |
0 |
2 |
0 |
| O9 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
1 |
0 |
1 |
0 |
3 |
| その他 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
| 累計 |
0 |
1 |
2 |
2 |
2 |
4 |
4 |
4 |
4 |
4 |
5 |
5 |
6 |
8 |
9 |
10 |
12 |
16 |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| O4 |
0 |
0 |
0 |
1 |
0 |
6 |
0 |
0 |
2 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
| O7 |
0 |
1 |
0 |
0 |
0 |
1 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
1 |
0 |
0 |
0 |
| O9 |
2 |
0 |
2 |
1 |
0 |
3 |
1 |
0 |
0 |
0 |
0 |
4 |
0 |
0 |
0 |
0 |
0 |
0 |
| その他 |
0 |
0 |
1 |
0 |
0 |
0 |
1 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
| 累計 |
18 |
19 |
22 |
24 |
24 |
34 |
36 |
36 |
38 |
38 |
38 |
42 |
43 |
43 |
44 |
45 |
45 |
45 |
（２）無症状病原体保有者調査
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| O4 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
0 |
0 |
0 |
2 |
0 |
2 |
0 |
0 |
0 |
0 |
| O7 |
0 |
0 |
0 |
1 |
0 |
0 |
1 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
1 |
0 |
2 |
0 |
| O9 |
0 |
0 |
2 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
0 |
0 |
0 |
0 |
4 |
1 |
| その他 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
1 |
1 |
| 累計 |
0 |
0 |
2 |
3 |
3 |
4 |
6 |
6 |
6 |
7 |
7 |
9 |
9 |
12 |
13 |
14 |
21 |
23 |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| O4 |
1 |
1 |
0 |
0 |
0 |
1 |
1 |
1 |
0 |
0 |
0 |
0 |
1 |
0 |
1 |
1 |
0 |
0 |
| O7 |
0 |
4 |
0 |
0 |
1 |
3 |
2 |
0 |
2 |
1 |
0 |
0 |
2 |
0 |
1 |
0 |
1 |
0 |
| O9 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
| その他 |
0 |
2 |
0 |
4 |
0 |
0 |
0 |
1 |
0 |
0 |
2 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
| 累計 |
24 |
31 |
31 |
35 |
36 |
40 |
43 |
45 |
47 |
48 |
50 |
50 |
53 |
53 |
55 |
57 |
58 |
58 |
|
